Status:
COMPLETED
Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD).
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborating Sponsors:
North American Mitochondrial Disease Consortium (NAMDC)
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Mitochondrial Diseases
Mitochondrial Myopathies
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The goal of this study is to find the best way to help people with primary mitochondrial disease deal with the stress of their condition, and to help these people be better able to "bounce back," or b...
Detailed Description
The investigators are going to test two interventions in this pilot study. The first is called Promoting Resilience in Stress Management (PRISM). The second is called clinical-focused narrative (CFN) ...
Eligibility Criteria
Inclusion
- Males or females at least 18 years old
- Capable of giving consent, or there is a legally authorized representative capable of giving consent on the subject behalf and if appropriate, assent.
- Able to speak and read English
- Able to participate in Web- and App-based interventions
- Confirmed molecular diagnosis of primary mitochondrial disease
Exclusion
- 1\. Suspected but no molecular diagnosis primary mitochondrial disease
Key Trial Info
Start Date :
September 22 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2024
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06051448
Start Date
September 22 2023
End Date
February 28 2024
Last Update
November 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104